Los puntos clave no están disponibles para este artículo en este momento.
Upregulation of CCNE1 by palbociclib confers resistance to palbociclib, which can be reverted by INK128
Goto et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: